DESIGN, WRITING AND PUBLICATION OF SCIENTIFIC MANUSCRIPTS – DESIGN OF SCIENTIFIC MANUSCRIPTS

Authors

  • Margarida Lima Hospital de Santo António, Centro Hospitalar do Porto

DOI:

https://doi.org/10.25753/BirthGrowthMJ.v22.i1.12904

Keywords:

Scientific education, design of scientific manuscripts

Abstract

In this first manuscript, from four that comprise the heading “DESIGN, WRITING AND PUBLISHING OF SCIENTIFIC MANUSCRIPTS”, as part of the “SCIENTIFIC EDUCATION” section of the journal “NASCER E CRESCER”, we reflect on the steps that should precede the writing of a scientific paper, in view to its publication in a periodic journal.

Downloads

Download data is not yet available.

References

Boyd JC, Rifai N, Annesley TM. Preparation of manuscripts

for publication: improving your chances for success. Clin.

Chem. 2009;55:1259–64.

Sharma S. How to become a competent medical writer?

Perspect. Clin. Res. 2010 Jan;1(1):33–7.

Masic I. How to Search, Write, Prepare and Publish the Scienti

Þ c Papers in the Biomedical Journals. Acta Inform. Medica.

;68–79.

Virella, D. A leitura crítica de um artigo médico (1a parte). Acta

Pediatr Port. 2009;40:37–41.

Virella, D. A leitura crítica de um artigo médico (2a parte).

;40:93–8.

Marusi􀃼 A, Marusi􀃼 M. Teaching students how to read and

write science: a mandatory course on scientiÞ c research and

communication in medicine. Acad. Med. J. Assoc. Am. Med.

Coll. 2003;78:1235–9.

Tomaska L. Teaching how to prepare a manuscript by means

of rewriting published scientiÞ c papers. Genetics.

;175:17–20.

Peh WC, Ng KH. Basic structure and types of scientiÞ c papers.

Singapore Med. J. 2008;49:522–5.

Hitchcock MA. Writing and publishing research articles. Fam.

Pract. Res. J. 1988;8:3–16.

Sollaci LB, Pereira MG. The introduction, methods, results,

and discussion (IMRAD) structure: a Þ fty -year survey. J. Med.

Libr. Assoc. Jmla. 2004;92:364–7.

Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardner

MJ. More informative abstracts revisited. Ann. Intern. Med.

;113:69–76.

Peh WCG, Ng KH. Writing a case report. Singapore Med. J.

;51:10–13; quiz 14.

Green BN, Johnson CD. How to write a case report for publication.

J. Chiropr. Med. 2006;5:72–82.

Crowe S, Cresswell K, Robertson A, Huby G, Avery A, Sheikh

A. The case study approach. Bmc Med. Res. Methodol.

;11:100.

Sorinola O, Olufowobi O, Coomarasamy A, Khan KS. Instructions

to authors for case reporting are limited: a review of a

core journal list. Bmc Med. Educ. 2004;4:4.

Virues -Ortega J, Moreno -Rodriguez R. Guidelines for clinical

case reports in behavioral clinical psychology. Int J Clin Heal.

Psychol. 2008;8:756–77.

Jabs DA. Improving the reporting of clinical case series. Am.

J. Ophthalmol. 2005;139:900–5.

Kempen JH. Appropriate use and reporting of uncontrolled

case series in the medical literature. Am. J. Ophthalmol.

;151:7–10.e1.

Ng KH, Peh WCG. Writing a technical note. Singapore Med.

J. 2010;51:101–103; quiz 104.

Peh WCG, Ng KH. Writing a pictorial essay. Singapore Med.

J. 2010;51:186–188; quiz 189.

Peh WC, Ng KH. Writing an invited review. Singapore Med. J.

;51:271–4.

Peh WC, Ng KH. Writing a book review. Singapore Med. J.

;51:685–8.

Derish PA, Annesley TM. How to write a rave review. Clin.

Chem. 2011;57:388–91.

Sampaio, RFE, Mancini, MC. Estudos de revisão sistemática:

um guia para síntese criteriosa da evidência cientíÞ ca. Rev

Bras Fisioter. 2007;11:83–9.

Mulrow CD. Rationale for systematic reviews. BMJ.

;309:597–9.

Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD,

Rennie D, et al. Meta -analysis of observational studies in epidemiology:

a proposal for reporting. Meta -analysis Of Observational

Studies in Epidemiology (MOOSE) group. Jama J.

Am. Med. Assoc. 2000;283:2008–12.

Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup

DF. Improving the quality of reports of meta -analyses of randomised

controlled trials: the QUOROM statement. Quality of

Reporting of Meta -analyses. Lancet. 1999;354:1896–900.

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC,

Ioannidis JPA, et al. The PRISMA statement for reporting systematic

reviews and meta -analyses of studies that evaluate

health care interventions: explanation and elaboration. Plos

Med. 2009;6:e1000100.

Reitsma JB, Moons KGM, Bossuyt PMM, Linnet K. Systematic

reviews of studies quantifying the accuracy of diagnostic

tests and markers. Clin. Chem. 2012;58:1534–45.

Peh WC, Ng KH. Writing a letter to the Editor. Singapore Med.

J. 2010;51:532–5.

Peh WC, Ng KH. Writing an editorial. Singapore Med. J.

;51:612–5.

Peh WCG, Ng KH. Writing an invited commentary. Singapore

Med. J. 2010;51:454–455; quiz 456.

Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et

al. Improving the quality of reporting of randomized controlled

trials. The CONSORT statement. Jama J. Am. Med. Assoc.

;276:637–9.

Rennie D. How to report randomized controlled trials. The CONSORT

statement. Jama J. Am. Med. Assoc. 1996;276:649.

Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC,

Vandenbroucke JP. The Strengthening the Reporting of Observational

Studies in Epidemiology (STROBE) statement: guidelines

for reporting observational studies. Plos Med. 2007;4:e296.

Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC,

Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of

Observational Studies in Epidemiology (STROBE): explanation

and elaboration. Plos Med. 2007;4:e297.

Benchimol EI, Langan S, Guttmann A. Call to RECORD:

the need for complete reporting of research using routinely

collected health data. J. Clin. Epidemiol. 2012; pii: S0895-

-4356(12)00280 -6.

Langan SM, Benchimol EI, Guttmann A, Moher D, Petersen

I, Smeeth L, et al. Setting the RECORD straight: developing

a guideline for the REporting of studies Conducted using

Observational Routinely collected Data. Clin. Epidemiol.

;5:29–31.

Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP,

Irwig LM, et al. Towards complete and accurate reporting of studies

of diagnostic accuracy: the STARD initiative. Standards for

Reporting of Diagnostic Accuracy. Clin. Chem. 2003;49:1–6.

Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou

PP, Irwig LM, et al. The STARD statement for reporting studies

of diagnostic accuracy: explanation and elaboration.

Clin. Chem. 2003;49:7–18.

Smidt N, Rutjes AWS, van der Windt DAWM, Ostelo RWJG,

Reitsma JB, Bossuyt PM, et al. Quality of reporting of diagnostic

accuracy studies. Radiology. 2005;235:347–53.

Simel DL, Rennie D, Bossuyt PMM. The STARD statement

for reporting diagnostic accuracy studies: application to

the history and physical examination. J. Gen. Intern. Med.

;23:768–74.

Rutjes AWS, Reitsma JB, Coomarasamy A, Khan KS, Bossuyt

PMM. Evaluation of diagnostic tests when there is no

gold standard. A review of methods. Heal. Technol. Assess.

Winch. Engl. 2007;11:iii, ix–51.

Reitsma JB, Rutjes AWS, Khan KS, Coomarasamy A, Bossuyt

PM. A review of solutions for diagnostic accuracy studies

with an imperfect or missing reference standard. J. Clin. Epidemiol.

;62:797–806.

McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion

M, Clark GM. Reporting recommendations for tumor marker

prognostic studies (REMARK). J. Natl. Cancer Inst.

;97:1180–4.

Little J, Higgins JPT, Ioannidis JPA, Moher D, Gagnon F, von

Elm E, et al. STrengthening the REporting of Genetic Association

Studies (STREGA): an extension of the STROBE statement.

Plos Med. 2009;6:e22.

Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JPA,

Kirsch -Volders M, et al. STrengthening the Reporting of OBservational

studies in Epidemiology - Molecular Epidemiology

(STROBE -ME): an extension of the STROBE statement. Eur.

J. Clin. Invest. 2012;42:1–16.

Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M,

Benigni A, et al. Recommendations for biomarker identiÞ cation

and qualiÞ cation in clinical proteomics. Sci. Transl. Med.

;2:46ps42.

Janssens ACJW, Ioannidis JPA, van Duijn CM, Little J, Khoury

MJ. Strengthening the reporting of Genetic RIsk Prediction

Studies: the GRIPS Statement. Plos Med. 2011;8:e1000420.

Newton PN, Lee SJ, Goodman C, Fernández FM, Yeung S,

Phanouvong S, et al. Guidelines for Þ eld surveys of the quality

of medicines: a proposal. Plos Med. 2009;6:e52.

Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards RI,

Fernandez AM, et al. Guidelines for submitting adverse event

reports for publication. Drug Saf. Int. J. Med. Toxicol. Drug

Exp. 2007;30:367–73.

Aronson JK. Anecdotes as evidence. BMJ. 2003;326:1346.

Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations

for reporting cost -effectiveness analyses. Panel

on Cost -Effectiveness in Health and Medicine. Jama J. Am.

Med. Assoc. 1996;276:1339–41.

Drummond M, Manca A, Sculpher M. Increasing the generalizability

of economic evaluations: recommendations for the

design, analysis, and reporting of studies. Int. J. Technol. Assess.

Health Care. 2005;21:165–71.

Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A,

et al. Good research practices for cost -effectiveness analysis

alongside clinical trials: the ISPOR RCT -CEA Task Force report.

Value Heal. J. Int. Soc. Pharmacoeconomics Outcomes

Res. 2005;8:521–33.

Petrou S, Gray A. Economic evaluation alongside randomised

controlled trials: design, conduct, analysis, and reporting.

BMJ. 2011;342:d1548.

Nuijten MJ, Pronk MH, Brorens MJ, Hekster YA, Lockefeer

JH, de Smet PA, et al. Reporting format for economic evaluation.

Part II: Focus on modelling studies. Pharmacoeconomics.

;14:259–68.

Petrou S, Gray A. Economic evaluation using decision analytical

modelling: design, conduct, analysis, and reporting. BMJ.

;342:d1766.

Vintzileos AM, Beazoglou T. Design, execution, interpretation,

and reporting of economic evaluation studies in obstetrics.

Am. J. Obstet. Gynecol. 2004;191:1070–6.

Nicholson A, Berger K, Bohn R, Carcao M, Fischer K, Gringeri

A, et al. Recommendations for reporting economic evaluations

of haemophilia prophylaxis: a nominal groups consensus

statement on behalf of the Economics Expert Working

Group of The International Prophylaxis Study Group. Haemoph.

Off. J. World Fed. Hemoph. 2008;14:127–32.

Davis JC, Robertson MC, Comans T, Scuffham PA. Guidelines for

conducting and reporting economic evaluation of fall prevention

strategies. Osteoporos. Int. J. Establ. Result Coop. Eur. Found.

Osteoporos. Natl. Osteoporos. Found. Usa. 2011;22:2449–59.

Peh WCG, Ng KH. Why write? Singapore Med. J.

;49:443–4.

Triaridis S, Kyrgidis A. Peer review and journal impact factor:

the two pillars of contemporary medical publishing. Hippokratia.

;14(Suppl 1):5–12.

The impact factor game. It is time to Þ nd a better way to assess

the scientiÞ c literature. Plos Med. 2006;3:e291.

Seglen PO. Why the impact factor of journals should not be

used for evaluating research. BMJ. 1997;314:498–502.

Ng KH. Exploring new frontiers of electronic publishing in biomedical

science. Singapore Med. J. 2009;50:230–4.

Davis PM, Walters WH. The impact of free access to the

scientiÞ c literature: a review of recent research. J. Med. Libr.

Assoc. Jmla. 2011;99:208–17.

Published

2017-08-22

How to Cite

1.
Lima M. DESIGN, WRITING AND PUBLICATION OF SCIENTIFIC MANUSCRIPTS – DESIGN OF SCIENTIFIC MANUSCRIPTS. REVNEC [Internet]. 2017Aug.22 [cited 2024Mar.28];22(1):50-9. Available from: https://revistas.rcaap.pt/nascercrescer/article/view/12904

Issue

Section

Scientific Education